| Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations JA Finegold, P Asaria, DP Francis International journal of cardiology 168 (2), 934-945, 2013 | 1215 | 2013 |
| What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid … JA Finegold, CH Manisty, B Goldacre, AJ Barron, DP Francis European journal of preventive cardiology 21 (4), 464-474, 2014 | 265 | 2014 |
| N-of-1 trial of a statin, placebo, or no treatment to assess side effects FA Wood, JP Howard, JA Finegold, AN Nowbar, DM Thompson, ... New England Journal of Medicine 383 (22), 2182-2184, 2020 | 254 | 2020 |
| 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations AN Nowbar, JP Howard, JA Finegold, P Asaria, DP Francis International journal of cardiology 174 (2), 293-298, 2014 | 210 | 2014 |
| Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis Y Ahmad, S Sen, MJ Shun-Shin, J Ouyang, JA Finegold, RK Al-Lamee, ... JAMA internal medicine 175 (6), 931-939, 2015 | 156 | 2015 |
| Side effect patterns in a crossover trial of statin, placebo, and no treatment JP Howard, FA Wood, JA Finegold, AN Nowbar, DM Thompson, ... Journal of the American College of Cardiology 78 (12), 1210-1222, 2021 | 129 | 2021 |
| Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility M Fontana, P Asaria, M Moraldo, J Finegold, K Hassanally, CH Manisty, ... Circulation 129 (24), 2539-2546, 2014 | 106 | 2014 |
| Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials SMA Sohaib, JA Finegold, SS Nijjer, R Hossain, C Linde, WC Levy, ... JACC: Heart Failure 3 (4), 327-336, 2015 | 86 | 2015 |
| Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function S Jones, J Lumens, SMA Sohaib, JA Finegold, P Kanagaratnam, ... Ep Europace 19 (7), 1178-1186, 2017 | 61 | 2017 |
| The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most? CE Raphael, JA Finegold, AJ Barron, ZI Whinnett, J Mayet, C Linde, ... European heart journal 36 (26), 1676-1688, 2015 | 50 | 2015 |
| Renal artery sympathetic denervation: observations from the UK experience ASP Sharp, JE Davies, MD Lobo, CL Bent, PB Mark, AE Burchell, ... Clinical Research in Cardiology 105, 544-552, 2016 | 34 | 2016 |
| Choosing between velocity-time-integral ratio and peak velocity ratio for calculation of the dimensionless index (or aortic valve area) in serial follow-up of aortic stenosis JA Finegold, CH Manisty, F Cecaro, N Sutaria, J Mayet, DP Francis International journal of cardiology 167 (4), 1524-1531, 2013 | 31 | 2013 |
| Quantification of survival gain from cardiac resynchronization therapy: non-linear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate … JAFMAMCRMAM Winnett PhD MRCP Darrel P Francis JACC, 2013 | 29* | 2013 |
| Automated aortic Doppler flow tracing for reproducible research and clinical measurements M Zolgharni, NM Dhutia, GD Cole, MR Bahmanyar, S Jones, SMA Sohaib, ... IEEE transactions on medical imaging 33 (5), 1071-1082, 2014 | 28 | 2014 |
| Automatic detection of end‐diastolic and end‐systolic frames in 2D echocardiography M Zolgharni, M Negoita, NM Dhutia, M Mielewczik, K Manoharan, ... Echocardiography 34 (7), 956-967, 2017 | 25 | 2017 |
| Distribution of lifespan gain from primary prevention intervention JA Finegold, MJ Shun-Shin, GD Cole, S Zaman, A Maznyczka, S Zaman, ... Open Heart 3 (1), e000343, 2016 | 24 | 2016 |
| Cardioprotective effect of hydroxysafflor yellow A via the cardiac permeability transition pore GA Huber, SM Priest, TP Geisbuhler Planta Medica 50 (08), 507-518, 2018 | 22 | 2018 |
| International RCT-based guidelines for use of preoperative stress testing and perioperative beta-blockers and statins in non-cardiac surgery AN Nowbar, GD Cole, MJ Shun-Shin, JA Finegold, DP Francis International journal of cardiology 172 (1), 138-143, 2014 | 20 | 2014 |
| Effect of study design on the reported effect of Cardiac Resynchronization Therapy (CRT) on quantitative physiological measures: stratified meta‐analysis in narrow‐QRS heart … RJ Jabbour, MJ Shun‐Shin, JA Finegold, SM Afzal Sohaib, C Cook, ... Journal of the American Heart Association 4 (1), e000896, 2015 | 17 | 2015 |
| What proportion of symptomatic side-effects in patients taking statins are genuinely caused by the drug? A response to letters JA Finegold, DP Francis European journal of preventive cardiology 22 (10), 1328-1330, 2015 | 13 | 2015 |
